【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1985次   下载 1706 本文二维码信息
码上扫一扫!
过氧化物酶体增殖物激活受体γ与糖尿病肾病
黄洁丽原爱红
0
(同济大学附属同济医院肾脏科,上海200065)
摘要:
过氧化物酶体增殖物激活受体(peroxisome proliferator-activated receptor,PPAR)属于核受体超家族成员,可分为三种亚型(PPARα、PPARβ/δ、PPARγ),PPARγ在脂肪形成、脂质代谢、胰岛素敏感性、炎症反应、动脉粥样硬化、血压调节等方面发挥重要作用,本文将就其与糖尿病肾病的关系作一综述。[著者文摘]
关键词:  糖尿病肾病 PPARγ 噻唑烷二酮类
DOI:10.3724/SP.J.1008.2006.01372
基金项目:
Peroxisome proliferator-activated receptor-alpha and diabetic nephropathy
HUANG Jie-li, YUAN Ai-hong
(Department of Nephrology, Tongji Hospital, Tongji University, Shanghai 200065, China)
Abstract:
Peroxisome proliferator-activated receptor (PPAR), a member of nuclear hormone receptor superfamily, has 3 subtypes, namely, PPARα, PPARβ/δ, and PPARγ; among them PPARγ plays an important role in adipogenesis, lipid metabolism, insulin sensitivity, inflammation, atherosclerosis, and blood pressure controlling. This article reviews the relationship between PPARγ and diabetic nephropathy.[著者文摘]
Key words:  diabetic nephropathies  PPAR gamma  thiazolidinediones